{"slideshow_credits": null, "snippet": "Mallinckrodt said that it expected the deal, the latest by a drug maker, to bolster its presence in hospitals.", "abstract": "DealBook Online; Mallinckrodt Pharmaceuticals says it will buy Ikaria, maker of treatments for critically sick infants, for $2.3 billion.", "section_name": "Business Day", "print_page": "5", "document_type": "article", "byline": {"person": [{"lastname": "de la MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. de la MERCED"}, "web_url": "http://www.nytimes.com/2015/03/06/business/dealbook/mallinckrodt-to-buy-drug-maker-ikaria-for-2-3-billion.html", "lead_paragraph": "Mallinckrodt said that it expected the deal, the latest by a drug maker, to bolster its presence in hospitals.", "headline": {"main": "Mallinckrodt to Buy Drug Maker Ikaria for $2.3 Billion", "print_headline": "Drug Maker Sold"}, "_id": "54f8611538f0d8579fff63bd", "word_count": "173", "multimedia": [], "pub_date": "2015-03-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Mallinckrodt Pharmaceuticals", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Madison Dearborn Partners", "is_major": "N", "rank": "3"}, {"name": "organizations", "value": "Pharmacyclics, Incorporated", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "5"}, {"name": "organizations", "value": "Ikaria Inc", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "Web Log"}